FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Feb. 29, 2012--
MEDNAX, Inc., (NYSE: MD) today announced that it is scheduled to make a
presentation on Monday, March 5, 2012, at 11 a.m. EST, to investors
attending the Raymond James 33rd Annual Institutional
Investors Conference in Orlando, Fla.
The presentation by MEDNAX’s Chief Financial Officer, Vivian
Lopez-Blanco will be broadcast through a live audio Webcast and will be
available for replay at www.mednax.com/investors.
ABOUT MEDNAX
MEDNAX, Inc., is a national medical group that comprises the nation's
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services as well as anesthesia services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
founded in 1979 and now includes neonatal physicians who provide
services at more than 300 neonatal intensive care units, who collaborate
with affiliated maternal-fetal medicine, pediatric cardiology and
pediatric critical care physician subspecialists to provide a clinical
care continuum. Pediatrix is also the nation's largest provider of
newborn hearing screens. In 2007, the Company expanded into anesthesia
services. Today, American Anesthesiology includes more than 900
anesthesiologists and advanced practitioners. MEDNAX, through its
affiliated professional corporations, employs more than 1,800 physicians
in 34 states and Puerto Rico. Additional information is available at www.mednax.com.
Source: MEDNAX, Inc.
MEDNAX, Inc.
David Parker, 954-384-0175, Ext. 5300
Vice
President, Corporate Communications & Investor Relations
david_parker@mednax.com